353 related articles for article (PubMed ID: 16378653)
1. Neuropeptide-Y Y2-receptor agonist, PYY3-36 promotes non-rapid eye movement sleep in rat.
Akanmu MA; Ukponmwan OE; Katayama Y; Honda K
Neurosci Res; 2006 Mar; 54(3):165-70. PubMed ID: 16378653
[TBL] [Abstract][Full Text] [Related]
2. Intravenous peptide YY3-36 and Y2 receptor antagonism in the rat: effects on feeding behaviour.
Scott V; Kimura N; Stark JA; Luckman SM
J Neuroendocrinol; 2005 Jul; 17(7):452-7. PubMed ID: 15946163
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin-induced sleep responses in ad libitum fed and food-restricted rats.
Szentirmai E; Hajdu I; Obal F; Krueger JM
Brain Res; 2006 May; 1088(1):131-40. PubMed ID: 16631138
[TBL] [Abstract][Full Text] [Related]
4. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.
Akanmu MA; Honda K
Brain Res; 2005 Jun; 1048(1-2):138-45. PubMed ID: 15919057
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic regulation of the central nucleus of the amygdala in rats: effects of local microinjections of cholinomimetics and cholinergic antagonists on arousal and sleep.
Sanford LD; Yang L; Tang X; Dong E; Ross RJ; Morrison AR
Neuroscience; 2006 Sep; 141(4):2167-76. PubMed ID: 16843604
[TBL] [Abstract][Full Text] [Related]
6. Studies on wakefulness-promoting effect of memantine in rats.
Ishida T; Obara Y; Kamei C
Behav Brain Res; 2010 Jan; 206(2):274-8. PubMed ID: 19781580
[TBL] [Abstract][Full Text] [Related]
7. Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121.
Olive MF; Seidel WF; Edgar DM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1073-83. PubMed ID: 9618410
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fluoromethylhistidine, a histamine synthesis inhibitor, inhibits orexin-induced wakefulness in rats.
Yasuko S; Atanda AM; Masato M; Kazuhiko Y; Kazuki H
Behav Brain Res; 2010 Feb; 207(1):151-4. PubMed ID: 19818811
[TBL] [Abstract][Full Text] [Related]
10. Tetrodotoxin inactivation of pontine regions: influence on sleep-wake states.
Sanford LD; Yang L; Tang X; Ross RJ; Morrison AR
Brain Res; 2005 May; 1044(1):42-50. PubMed ID: 15862788
[TBL] [Abstract][Full Text] [Related]
11. Obestatin alters sleep in rats.
Szentirmai E; Krueger JM
Neurosci Lett; 2006 Aug; 404(1-2):222-6. PubMed ID: 16806691
[TBL] [Abstract][Full Text] [Related]
12. Gadolinium chloride pretreatment prevents cafeteria diet-induced sleep in rats.
Hansen MK; Krueger JM
Sleep; 1999 Sep; 22(6):707-15. PubMed ID: 10505816
[TBL] [Abstract][Full Text] [Related]
13. Neuromedin U(2) receptor signaling mediates alteration of sleep-wake architecture in rats.
Ahnaou A; Drinkenburg WH
Neuropeptides; 2011 Apr; 45(2):165-74. PubMed ID: 21296417
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption.
Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M
J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429
[TBL] [Abstract][Full Text] [Related]
15. Effects of neuropeptide Y on food intake and brain biogenic amines in the rainbow trout (Oncorhynchus mykiss).
Aldegunde M; Mancebo M
Peptides; 2006 Apr; 27(4):719-27. PubMed ID: 16253390
[TBL] [Abstract][Full Text] [Related]
16. The GABAA receptor agonist THIP alters the EEG in waking and sleep of mice.
Vyazovskiy VV; Kopp C; Bösch G; Tobler I
Neuropharmacology; 2005 Apr; 48(5):617-26. PubMed ID: 15814097
[TBL] [Abstract][Full Text] [Related]
17. PYY3-36 as an anti-obesity drug target.
Boggiano MM; Chandler PC; Oswald KD; Rodgers RJ; Blundell JE; Ishii Y; Beattie AH; Holch P; Allison DB; Schindler M; Arndt K; Rudolf K; Mark M; Schoelch C; Joost HG; Klaus S; Thöne-Reineke C; Benoit SC; Seeley RJ; Beck-Sickinger AG; Koglin N; Raun K; Madsen K; Wulff BS; Stidsen CE; Birringer M; Kreuzer OJ; Deng XY; Whitcomb DC; Halem H; Taylor J; Dong J; Datta R; Culler M; Ortmann S; Castañeda TR; Tschöp M
Obes Rev; 2005 Nov; 6(4):307-22. PubMed ID: 16246216
[TBL] [Abstract][Full Text] [Related]
18. The effect of peptide tyrosine tyrosine (PYY3-36), a selective Y2 receptor agonist on streptozotocin-induced diabetes in albino rats.
Abdel-Hamid HA; Abdalla MMI; Zenhom NM; Ahmed RF
Endocr Regul; 2019 Jan; 53(1):26-33. PubMed ID: 31517617
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.
Ivarsson M; Paterson LM; Hutson PH
Eur J Pharmacol; 2005 Oct; 522(1-3):63-71. PubMed ID: 16223479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
